One‐Day Versus Three‐Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy‐Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data‐Based Meta‐Analysis

BACKGROUND. A dexamethasone‐sparing regimen consisting of palonosetron plus 1‐day dexamethasone for the prevention of chemotherapy‐induced nausea and vomiting (CINV) has been studied previously. Here, we evaluate the noninferiority of the dexamethasone‐sparing regimen in overall antiemetic control u...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Yuki, Oba, Koji, Furukawa, Naoto, Kosaka, Yoshimasa, Okita, Kenji, Yuki, Satoshi, Komatsu, Yoshito, Celio, Luigi, Aapro, Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975929/
https://www.ncbi.nlm.nih.gov/pubmed/31217343
http://dx.doi.org/10.1634/theoncologist.2019-0133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975929/
https://www.ncbi.nlm.nih.gov/pubmed/31217343
http://dx.doi.org/10.1634/theoncologist.2019-0133

Ejemplares similares